Jeffrey P. Raimondi

FDA investigator

Appears on 40 documents from 2017 to 2026, most often at sites in California. Most often cites design and construction features (21 CFR 211.42).

40
Documents on file
6.5
Observations per 483
2017
First seen
2026
Most recent

What they cite most

From 259 observations

Activity by year

2017: 3, 2018: 1, 2019: 5, 2020: 4, 2021: 3, 2022: 3, 2023: 7, 2024: 5, 2025: 8, 2026: 1

Where

California 14 · India 13 · China 3 · Washington 2 · Arizona 1 · France 1

Is Jeffrey P. Raimondi coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

40 documents, newest first
FirmOpen
483 Cipla LimitedApr 17, 2026 · Salcette, India
483 NerPharMa S.r.l.Jun 27, 2025 · Nerviano, Milan, Italy
483 Eli Lilly and CompanyMay 20, 2025 · Indianapolis, Indiana
483 Ajinomoto Althea, IncMay 9, 2025 · San Diego, California
483 PCI San Diego, Inc.May 9, 2025 · San Diego, California
483 Creative Essences IncMar 25, 2025 · Santa Fe Springs, California
483 Form 483 · FEI 3018521591Mar 18, 2025 · Glendale, California

About this profile

What does Jeffrey P. Raimondi inspect?

Jeffrey P. Raimondi appears on 40 documents on file covering 36 sites, most often in California.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jeffrey P. Raimondi is dated Apr 17, 2026.